Company intelligence / Profile preview

RNAissance Ag

St. Louis, Missouri, USArnaissanceag.net ↗

Ownership: Private
Development stage: Preclinical

Overview

RNAissance Ag develops environmentally friendly and highly specific sprayable RNA-based biopesticides for crop protection. Their products are designed to target specific agricultural pests without harming beneficial insects or other organisms. The company has demonstrated efficacy in field trials against major crop pests such as the Diamondback Moth and Fall Armyworm but does not yet have commercialized products.

Therapeutic areas: Other
Modalities: RNA interference
Industry: Agriculture & AgTech

Drug pipeline

2 assets

RNAi biopesticide for Diamondback Moth

Pre-clinical

Indications: Agricultural pest control

1 more asset in the full pipeline.

Request access →

Partnerships

Donald Danforth Plant Science CenterGreenLight Biosciences Inc.AgroSpheres Inc.

Beyond the preview

Go deeper on RNAissance Ag.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNAissance Ag.

Explore the full profile